BSE: FDC - FDC Limited

Rentabilidad a seis meses: -2.66%

Calendario de promoción FDC Limited


Acerca de la empresa

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients.

más detalles
It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.

ISIN INE258B01022
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.9778
Дивиденд ао 5
Сайт https://www.fdcindia.com
Цена ао 473.8
Cambio de precio por día: +1.58% (473.8)
Cambio de precio por semana.: -4.9% (506.1)
Cambio de precio por mes: -4.3% (502.95)
Cambio de precio en 3 meses.: -14.75% (564.6)
Cambio de precio en seis meses: -2.66% (494.45)
Cambio de precio por año: +14.87% (419)
Cambio de precio en 3 años.: +59.79% (301.2)
Cambio de precio en 5 años.: +142.71% (198.3)
Cambio de precio en 10 años.: 0% (481.3)
Cambio de precio desde principios de año.: -5.53% (509.5)

Subestimación

Nombre Significado Calificación
P/S 3.28 5
P/BV 3.04 5
P/E 20.91 7
EV/EBITDA 15.83 6
Total: 6.25

Eficiencia

Nombre Significado Calificación
ROA, % 12.37 4
ROE, % 14.55 4
Total: 3

Dividendos

Nombre Significado Calificación
Div yield, % 0.9778 2.45
DSI 0.9286 9.29
Total: 2.18

Deber

Nombre Significado Calificación
Debt/EBITDA 0.000926 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 44.54 6
Rentabilidad Ebitda, % -16.49 0
Rentabilidad EPS, % 47.4 6
Total: 3.2

ETF Compartir, % Rentabilidad del año, % Dividendos, %
iShares MSCI India Small-Cap ETF 0.07869 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.02919 5.46 3.03583
SPDR Portfolio Emerging Markets ETF 0.01949 11.59 3.1879
WisdomTree India Earnings Fund 0.01108 5.23 1.65591
Avantis Responsible Emerging Markets Equity ETF 0.0081 17.6 3.1719
Dimensional Emerging Markets Core Equity 2 ETF 0.00622 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.00327 8.77 3.60513
iShares Core MSCI Total International Stock ETF 0.00273 6.4 3.25258
Dimensional Emerging Markets Value ETF 0.00011 17.07 4.19508

Supervisor Título profesional Pago año de nacimiento
Dr. Nandan Mohan Chandavarkar Joint MD & Executive Director 24.41M
Mr. Mohan Anand Chandavarkar BR Head, MD & Director 31.81M
Mr. Sanjay B. Jain Vice President of Corporate Finance N/A
Ms. Varsharani Rajaram Katre C.S. Compliance Officer & Company Secretary N/A
Mr. Ameya Ashok Chandavarkar CEO of International Business & Executive Director 16.23M 1978 (47 años)
Mr. Ashok Anand Chandavarkar Whole Time Director 17.11M
Mr. Vijay Dharmadatt Bhatt Chief Financial Officer N/A
Mr. Lalit Aggarwal President of Technical & Operations N/A
Mr. Shashank Vyapari Associate Vice President of Technical & Operations
Mr. Anant Kharche Associate Vice President of Engineering Services & Projects

DIRECCIÓN: India, Mumbai, C/3 Skyvistas - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.fdcindia.com